Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS

Clinical trial NCT03905707 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03905707
Sponsor: Zealand Pharma
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Short Bowel Syndrome

Start date: 2019-05-07
Primary completion: 2026-04-01
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.